The anatomic location of pancreatic cancer is a prognostic factor for survival

HPB

Volumn 10, Issue 5, 2008, Pages 371-376

  Artinyan, Avo ^a   Soriano, Perry A ^a   Prendergast, Christina ^a   Low, Tracey ^a   Ellenhorn, Joshua D I ^a   Kim, Joseph ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Pancreatic cancer; SEER; Tumor location

Indexed keywords

AGE; AGED; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATIONAL STUDY; FACTORIAL ANALYSIS; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

EID: 54549088019     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820802291233     Document Type: Conference Paper

References (32)

1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. and Thun, MJ. (2007) Cancer statistics, 2007. CA Cancer J Clin, 57, pp. 43-66.
2. Winter, JM, Cameron, JL, Campbell, KA, Arnold, MA, Chang, DC Coleman, J. et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg, 10, pp. 1199-1210.
3. Greer, SE, Pipas, JM, Sutton, JE, Zaki, BI, Tsapakos, M. Colacchio, TA et al. (2008) Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma. J Am Coll Surg, 206, pp. 451-457.
4. Picozzi, VJ, Kozarek, RA and Traverso, LW. (2003) Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg, 185, pp. 476-480.
5. Hines, OJ and Reber, HA. (2006) Pancreatic surgery. Curr Opin Gastroenterol., 22, pp. 520-526.
6. Cameron, JL, Riall, TS, Coleman, J. and Belcher, KA. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg, 244, pp. 10-15.
7. Griffin, JF, Smalley, SR, Jewell, W., Paradelo, JC, Reymond, RD Hassanein, RE et al. (1990) Patterns of failure after curative resection of pancreatic carcinoma. Cancer, 66, pp. 56-61.
8. Geer, RJ and Brennan, MF. (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg, 165, pp. 68-72.
9. Nitecki, SS, Sarr, MG, Colby, TV and van Heerden, JA. (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?. Ann Surg, 221, pp. 59-66.
10. Brennan, MF, Moccia, RD and Klimstra, D. (1996) Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg, 223, pp. 506-511.
11. Wade, TP, Virgo, KS and Johnson, FE. (1987) Distal pancreatectomy for cancer: Results in US department of Veterans affairs hospitals, -1991. Pancreas;11, 1995, pp. 341-344.
12. Watanabe, I., Sasaki, S., Konishi, M., Nakagohri, T., Inoue, K. Oda, T. et al. (2004) Onset symptoms and tumor locations as prognostic factors of pancreatic cancer. Pancreas, 28, pp. 160-165.
13. Greenlee, RT, Murray, T., Bolden, S. and Wingo, PA. (2000) Cancer statistics, 2000. CA Cancer J Clin, 50, pp. 7-33.
14. Kalser, MH, Barkin, J. and MacIntyre, JM. (1985) Pancreatic cancer. Assessment of prognosis by clinical presentation. Cancer, 56, pp. 397-402.
15. Sohn, TA, Yeo, CJ, Cameron, JL, Koniaris, L., Kaushal, S. Abrams, RA et al. (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg, 4, pp. 567-579.
16. Surveillance, Epidemiology, and End Results (SEER) About SEER. National Cancer Institute.
17. Schwarz, RE and Smith, DD. (2006) Extent of lymph node retrieval and pancreatic cancer survival: Information from a large US population database. Ann Surg Oncol, 13, pp. 1189-1200.
18. Pawlik, TM, Gleisner, AL, Cameron, JL, Winter, JM, Assumpcao, L. Lillemoe, KD et al. (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surg, 141, pp. 610-618.
19. Tomlinson, JS, Jain, S., Bentrem, DJ, Sekeris, EG, Maggard, MA Hines, OJ et al. (2007) Accuracy of staging node-negative pancreas cancer: A potential quality measure. Arch Surg, 142, p. 767.
20. Hellan, M., Sun, CL, Artinyan, A., Mojica-Manosa, P., Bhatia, S. Ellenhorn, JDI et al. (2008) The impact of lymph node number on survival in patients with lymph node negative pancreatic cancer. Pancreas, 37, pp. 19-24.
21. Iacono, C., Accordini, S., Bortolasi, L., Facci, E., Zamboni, G. Montresor, E. et al. (2002) Results of pancreaticoduodenectomy for pancreatic cancer: Extended versus standard procedure. World J Surg, 26, pp. 1309-1314.
22. Gazzaniga, GM, Cappato, S., Papadia, F., Mori, L. and Filauro, M. (2001) D1 versus D2 pancreatoduodenectomy in surgical therapy of pancreatic head cancer. Hepatogastroenterol, 48, pp. 1471-1478.
23. Farnell, MB, Pearson, RK, Sarr, MG, DiMagno, EP, Burgart, LJ Dahl, TR et al. (2005) A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surg, 138, pp. 618-628.
24. Pedrazzoli, S., DiCarlo, V., Dionigi, R., Mosca, F., Pederzoli, P. Pasquali, C. et al. (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg, 228, pp. 508-517.
25. Yeo, CJ, Cameron, JL, Lillemoe, KD, Sohn, TA, Campbell, KA Sauter, PK et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg, 236, pp. 355-366.
26. Balcom, JH, Rattner, DW, Warshaw, AL, Chang, Y. and Fernandez-del Castillo, C. (2001) Ten-year experience with 733 pancreatic resections. Changing indications, older patients, and decreasing length of hospitalization. Arch Surg, 136, pp. 391-398.
27. Christein, JD, Kendrick, ML, Iqbal, CW, Nagorney, DM and Farnell, MB. (2005) Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J Gastrointest Surg, 9, pp. 922-927.
28. Goh, BK, Tan, YM, Cheow, PC, Chung, YF, Chow, PK Wong, WK et al. (2008) Outcome of distal pancreatectomy for pancreatic adenocarcinoma. Dig Surg, 25, pp. 32-38.
29. Westgaard, A., Tafjord, S., Farstad, IN, Cvancarova, M., Eide, TJ Mathisen, O. et al. (2008) Resectable adenocarcinomas in the pancreatic head: The retroperitoneal resection margin is an independent prognostic factor. BMC Cancer, 8, p. 5.
30. Winter, JM, Cameron, JL, Campbell, KA, Arnold, MA, Chang, DC Coleman, J. et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg, 10, pp. 1199-1210.
31. Neoptolemos, JP, Stocken, DD, Friess, H., Bassi, C., Dunn, JA Hickey, H. et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med, 350, pp. 1200-1210.
32. Stocken, DD, Buchler, MW, Dervenis, C., Bassi, C., Jeekel, H. Klinkenbijl, JH et al. (2005) Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer, 92, pp. 1372-1381.